These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2495256)

  • 21. Serum lipid profile in pubescent athletes.
    Taralov Z; Boyadjiev N; Georgieva K
    Acta Physiol Pharmacol Bulg; 2000; 25(1):3-8. PubMed ID: 11140190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sex hormones and the changes in adolescent male lipids: longitudinal studies in a biracial cohort.
    Morrison JA; Barton BA; Biro FM; Sprecher DL
    J Pediatr; 2003 Jun; 142(6):637-42. PubMed ID: 12838191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced high-density lipoprotein-cholesterol in power athletes: use of male sex hormone derivates, an atherogenic factor.
    Alén M; Rahkila P
    Int J Sports Med; 1984 Dec; 5(6):341-2. PubMed ID: 6511154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Aminoglutethimide-induced dyslipemia. Clinical study].
    Bonneterre J; Nguyen M; Hecquet B; Fournier C; Demaille A
    Bull Cancer; 1985; 72(2):99-103. PubMed ID: 3924146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flow-mediated, endothelium-dependent vasodilatation is impaired in male body builders taking anabolic-androgenic steroids.
    Ebenbichler CF; Sturm W; Gänzer H; Bodner J; Mangweth B; Ritsch A; Sandhofer A; Lechleitner M; Föger B; Patsch JR
    Atherosclerosis; 2001 Oct; 158(2):483-90. PubMed ID: 11583730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Androgenic-anabolic steroid effects on serum and skin surface lipids, on red cells, and on liver enzymes.
    Király CL
    Int J Sports Med; 1988 Aug; 9(4):249-52. PubMed ID: 2972634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anabolic androgenic steroids produce dose-dependant increase in left ventricular mass in power atheletes, and this effect is potentiated by concomitant use of growth hormone.
    Karila TA; Karjalainen JE; Mäntysaari MJ; Viitasalo MT; Seppälä TA
    Int J Sports Med; 2003 Jul; 24(5):337-43. PubMed ID: 12868044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The abuse of doping agents in competing body builders in Flanders (1988-1993).
    Delbeke FT; Desmet N; Debackere M
    Int J Sports Med; 1995 Jan; 16(1):66-70. PubMed ID: 7713634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coronary calcification in body builders using anabolic steroids.
    Santora LJ; Marin J; Vangrow J; Minegar C; Robinson M; Mora J; Friede G
    Prev Cardiol; 2006; 9(4):198-201. PubMed ID: 17085981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anabolic steroid use in body builders: an echocardiographic study of left ventricle morphology and function.
    De Piccoli B; Giada F; Benettin A; Sartori F; Piccolo E
    Int J Sports Med; 1991 Aug; 12(4):408-12. PubMed ID: 1917226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular effects of anabolic steroids in weight-trained subjects.
    Palatini P; Giada F; Garavelli G; Sinisi F; Mario L; Michieletto M; Baldo-Enzi G
    J Clin Pharmacol; 1996 Dec; 36(12):1132-40. PubMed ID: 9013370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endocrine effects in female weight lifters who self-administer testosterone and anabolic steroids.
    Malarkey WB; Strauss RH; Leizman DJ; Liggett M; Demers LM
    Am J Obstet Gynecol; 1991 Nov; 165(5 Pt 1):1385-90. PubMed ID: 1835565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physical health and fitness of an elite bodybuilder during 1 year of self-administration of testosterone and anabolic steroids: a case study.
    Alén M; Häkkinen K
    Int J Sports Med; 1985 Feb; 6(1):24-9. PubMed ID: 3921472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of concomitant use of alcohol, tobacco, cocaine, and anabolic steroids on lipid profiles of Brazilian recreational bodybuilders.
    Schwingel PA; Zoppi CC; Cotrim HP
    Subst Use Misuse; 2014 Jul; 49(9):1115-25. PubMed ID: 24766402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resistance trained athletes using or not using anabolic steroids compared to runners: effects on cardiorespiratory variables, body composition, and plasma lipids.
    Yeater R; Reed C; Ullrich I; Morise A; Borsch M
    Br J Sports Med; 1996 Mar; 30(1):11-4. PubMed ID: 8665108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The adverse effects of anabolic steroids on serum lipids.
    Labib M; Haddon A
    Ann Clin Biochem; 1996 May; 33 ( Pt 3)():263-4. PubMed ID: 8791993
    [No Abstract]   [Full Text] [Related]  

  • 37. Increased left ventricular mass in a bodybuilder using anabolic steroids.
    McKillop G; Todd IC; Ballantyne D
    Br J Sports Med; 1986 Dec; 20(4):151-2. PubMed ID: 2949795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxidative stress and myocardial dysfunction in young rabbits after short term anabolic steroids administration.
    Germanakis I; Tsarouhas K; Fragkiadaki P; Tsitsimpikou C; Goutzourelas N; Champsas MC; Stagos D; Rentoukas E; Tsatsakis AM
    Food Chem Toxicol; 2013 Nov; 61():101-5. PubMed ID: 23537599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. One- and two-dimensional echocardiography in bodybuilders using anabolic steroids.
    Urhausen A; Hölpes R; Kindermann W
    Eur J Appl Physiol Occup Physiol; 1989; 58(6):633-40. PubMed ID: 2731533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Left ventricular function is not impaired in weight-lifters who use anabolic steroids.
    Thompson PD; Sadaniantz A; Cullinane EM; Bodziony KS; Catlin DH; Torek-Both G; Douglas PS
    J Am Coll Cardiol; 1992 Feb; 19(2):278-82. PubMed ID: 1531057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.